Search
for
Sort by
Research 121–150 of 1000+
- Pharmaceutical Sciences & Analytical Research Journal
- Medicinal Plants for Skin Health: A Holistic Review of Botanical Interventions
- Antitumor Activities of the Typhonium flagelliforme Extract Combined with Natural Interferons of Canine and Feline in Mice with DMBA Induced Skin Tumors
- British Hair and Nail Society
- Skin Diseases (Noncancerous)
- Index
- Cytostatics and immunosuppressive drugs
- Westwood Carolina Conference on Clinical Dermatology
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades
- CD4 expression controls epidermal stem cell balance
- Harmless Herbs? A Review of the Recent Literature
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Is dehydroepiandrosterone a hormone?
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- Hair growth and rejuvenation: An overview
- Management of Hair Loss
- Niosomes as a propitious carrier for topical drug delivery
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Oestrogen functions in skin and skin appendages
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Imbalance of T‐helper 17 and regulatory T cells in patients with alopecia areata
- Role of -catenin in Epidermal Stem Cell Expansion, Lineage Selection, and Cancer
- Oral Retinoids in Dermatology
- Diagnosis and Management of Alopecia in Children
- Advances in the management of alopecia areata
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis